Detalhe da pesquisa
1.
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin.
Bioorg Med Chem Lett
; 17(12): 3384-7, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17433672